Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer

Masayuki Shirasawa, Tatsuya Yoshida, Tatsuya Imabayashi, Kae Okuma, Yuji Matsumoto, Ken Masuda, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Takaaki Tsuchida, Noboru Yamamoto, Yuko Nakayama, Shun‐ichi Watanabe, Noriko Motoi, Yuichiro Ohe